ISRG). The Company posted its first quarter fiscal 2017 results on April 18, 2017. The robotic surgery system Company surpassed top- and bottom-line expectations. Register with us now for your free membership at: http://www.activewallst.com/register/.

One of Intuitive Surgical's competitors within the Medical Appliances & Equipment space, Zimmer Biomet Holdings, Inc. (NYSE: ZBH), is estimated to report earnings on April 27, 2017. AWS will be initiating a research report on Zimmer Biomet following the release of its next earnings results.

Today, AWS is promoting its earnings coverage on ISRG; touching on ZBH. Get our free coverage by signing up to: http://www.activewallst.com/register/.

Earnings Reviewed

For the three months ended March 31, 2017, Intuitive Surgical's revenue was $674 million, up approximately 13% compared with $595 million in Q1 FY16. The increase in revenue was driven by growth in recurring instrument, accessory, and service revenue, and higher systems revenue. The Company's revenue numbers surpassed analysts' consensus of $660.6 million.

For Q1 FY17, Intuitive Surgical's instrument and accessory revenue had increased by approximately 18% to $381 million compared with $322 million for Q1 FY16, primarily driven by nearly 18% growth in da Vinci procedure volume. The Company's service revenue had increased by approximately 13% to $140 million in the reported quarter compared with $125 million in the year earlier same quarter.

For Q1 FY17, Intuitive Surgical's systems revenue increased by approximately 4% to $153 million compared with $148 million for Q1 FY16. Intuitive Surgical shipped 133 da Vinci Surgical Systems in the reported quarter compared with 110 in the year earlier comparable quarter.

Intuitive Surgical's Q1 FY17 income from operations increased to $192 million compared with $179 million in Q1 FY16. The Company's reported quarter non-GAAP income from operations increased to $264 million compared with $229 million in the year earlier corresponding quarter.

Intuitive Surgical's Q1 FY17 GAAP net income was $180 million, or $4.67 per diluted share, compared with $136 million, or $3.54 per diluted share, for Q1 FY16. The Company's reported quarter GAAP net income benefited from the adoption of a new accounting standard which required that $33 million, or $0.85 per share, of excess tax benefits related to employee share-based compensation awards be recorded as a component of income tax expense. For Q1 FY17 results also included pre-tax litigation charges of approximately $21 million, or $0.39 per share net of income tax.

The Company's non-GAAP net income was $196 million, or $5.09 per diluted share, for the reported quarter compared with $170 million, or $4.42 per diluted share, for the prior year quarter. The results topped Wall Street's estimates of $4.90 per share.

Surgical Highlights

For Q1 FY17, Intuitive Surgical's worldwide da Vinci procedures grew nearly 18% on a y-o-y basis, driven primarily by growth in US general surgery procedures and worldwide urologic procedures. The Company shipped 133 da Vinci Surgical Systems in the reported quarter compared with 110 in the year earlier same quarter.

Cash Flow

Intuitive Surgical ended Q1 FY17 with $3.1 billion in cash, cash equivalents, and investments, a decrease of $1.7 billion during the reported quarter, primarily driven by the $2 billion used for accelerated share repurchases, yet partially offset by proceeds from cash generated from operations and employee stock option exercises.

Stock Performance

At the close of trading session on Thursday, April 20, 2017, Intuitive Surgical's share price finished yesterday's trading session at $814.45, rising slightly by 0.84%. A total volume of 394.36 thousand shares exchanged hands, which was higher than the 3 months average volume of 356.40 thousand shares. The stock has surged 23.77% and 26.36% in the last three months and past twelve months, respectively. Furthermore, since the start of the year, shares of the Company have surged 28.43%. The stock is trading at a PE ratio of 43.52 and currently has a market cap of $29.91 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 460226

"/> Post Earnings Coverage as Intuitive Surgical’s Quarterly Revenue Increased 13%; EPS Gained 15% « MarketersMedia – Press Release Distribution Services – News Release Distribution Services

Post Earnings Coverage as Intuitive Surgical’s Quarterly Revenue Increased 13%; EPS Gained 15%

Upcoming AWS Coverage on Zimmer Biomet Holdings

LONDON, UK / ACCESSWIRE / April 21, 2017 / Active Wall St. announces its post-earnings coverage on Intuitive Surgical, Inc. (NASDAQ: ISRG). The Company posted its first quarter fiscal 2017 results on April 18, 2017. The robotic surgery system Company surpassed top- and bottom-line expectations. Register with us now for your free membership at: http://www.activewallst.com/register/.

One of Intuitive Surgical's competitors within the Medical Appliances & Equipment space, Zimmer Biomet Holdings, Inc. (NYSE: ZBH), is estimated to report earnings on April 27, 2017. AWS will be initiating a research report on Zimmer Biomet following the release of its next earnings results.

Today, AWS is promoting its earnings coverage on ISRG; touching on ZBH. Get our free coverage by signing up to: http://www.activewallst.com/register/.

Earnings Reviewed

For the three months ended March 31, 2017, Intuitive Surgical's revenue was $674 million, up approximately 13% compared with $595 million in Q1 FY16. The increase in revenue was driven by growth in recurring instrument, accessory, and service revenue, and higher systems revenue. The Company's revenue numbers surpassed analysts' consensus of $660.6 million.

For Q1 FY17, Intuitive Surgical's instrument and accessory revenue had increased by approximately 18% to $381 million compared with $322 million for Q1 FY16, primarily driven by nearly 18% growth in da Vinci procedure volume. The Company's service revenue had increased by approximately 13% to $140 million in the reported quarter compared with $125 million in the year earlier same quarter.

For Q1 FY17, Intuitive Surgical's systems revenue increased by approximately 4% to $153 million compared with $148 million for Q1 FY16. Intuitive Surgical shipped 133 da Vinci Surgical Systems in the reported quarter compared with 110 in the year earlier comparable quarter.

Intuitive Surgical's Q1 FY17 income from operations increased to $192 million compared with $179 million in Q1 FY16. The Company's reported quarter non-GAAP income from operations increased to $264 million compared with $229 million in the year earlier corresponding quarter.

Intuitive Surgical's Q1 FY17 GAAP net income was $180 million, or $4.67 per diluted share, compared with $136 million, or $3.54 per diluted share, for Q1 FY16. The Company's reported quarter GAAP net income benefited from the adoption of a new accounting standard which required that $33 million, or $0.85 per share, of excess tax benefits related to employee share-based compensation awards be recorded as a component of income tax expense. For Q1 FY17 results also included pre-tax litigation charges of approximately $21 million, or $0.39 per share net of income tax.

The Company's non-GAAP net income was $196 million, or $5.09 per diluted share, for the reported quarter compared with $170 million, or $4.42 per diluted share, for the prior year quarter. The results topped Wall Street's estimates of $4.90 per share.

Surgical Highlights

For Q1 FY17, Intuitive Surgical's worldwide da Vinci procedures grew nearly 18% on a y-o-y basis, driven primarily by growth in US general surgery procedures and worldwide urologic procedures. The Company shipped 133 da Vinci Surgical Systems in the reported quarter compared with 110 in the year earlier same quarter.

Cash Flow

Intuitive Surgical ended Q1 FY17 with $3.1 billion in cash, cash equivalents, and investments, a decrease of $1.7 billion during the reported quarter, primarily driven by the $2 billion used for accelerated share repurchases, yet partially offset by proceeds from cash generated from operations and employee stock option exercises.

Stock Performance

At the close of trading session on Thursday, April 20, 2017, Intuitive Surgical's share price finished yesterday's trading session at $814.45, rising slightly by 0.84%. A total volume of 394.36 thousand shares exchanged hands, which was higher than the 3 months average volume of 356.40 thousand shares. The stock has surged 23.77% and 26.36% in the last three months and past twelve months, respectively. Furthermore, since the start of the year, shares of the Company have surged 28.43%. The stock is trading at a PE ratio of 43.52 and currently has a market cap of $29.91 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 460226

Upcoming AWS Coverage on Zimmer Biomet Holdings

LONDON, UK / ACCESSWIRE / April 21, 2017 / Active Wall St. announces its post-earnings coverage on Intuitive Surgical, Inc. (NASDAQ: ISRG). The Company posted its first quarter fiscal 2017 results on April 18, 2017. The robotic surgery system Company surpassed top- and bottom-line expectations. Register with us now for your free membership at: http://www.activewallst.com/register/.

One of Intuitive Surgical's competitors within the Medical Appliances & Equipment space, Zimmer Biomet Holdings, Inc. (NYSE: ZBH), is estimated to report earnings on April 27, 2017. AWS will be initiating a research report on Zimmer Biomet following the release of its next earnings results.

Today, AWS is promoting its earnings coverage on ISRG; touching on ZBH. Get our free coverage by signing up to: http://www.activewallst.com/register/.

Earnings Reviewed

For the three months ended March 31, 2017, Intuitive Surgical's revenue was $674 million, up approximately 13% compared with $595 million in Q1 FY16. The increase in revenue was driven by growth in recurring instrument, accessory, and service revenue, and higher systems revenue. The Company's revenue numbers surpassed analysts' consensus of $660.6 million.

For Q1 FY17, Intuitive Surgical's instrument and accessory revenue had increased by approximately 18% to $381 million compared with $322 million for Q1 FY16, primarily driven by nearly 18% growth in da Vinci procedure volume. The Company's service revenue had increased by approximately 13% to $140 million in the reported quarter compared with $125 million in the year earlier same quarter.

For Q1 FY17, Intuitive Surgical's systems revenue increased by approximately 4% to $153 million compared with $148 million for Q1 FY16. Intuitive Surgical shipped 133 da Vinci Surgical Systems in the reported quarter compared with 110 in the year earlier comparable quarter.

Intuitive Surgical's Q1 FY17 income from operations increased to $192 million compared with $179 million in Q1 FY16. The Company's reported quarter non-GAAP income from operations increased to $264 million compared with $229 million in the year earlier corresponding quarter.

Intuitive Surgical's Q1 FY17 GAAP net income was $180 million, or $4.67 per diluted share, compared with $136 million, or $3.54 per diluted share, for Q1 FY16. The Company's reported quarter GAAP net income benefited from the adoption of a new accounting standard which required that $33 million, or $0.85 per share, of excess tax benefits related to employee share-based compensation awards be recorded as a component of income tax expense. For Q1 FY17 results also included pre-tax litigation charges of approximately $21 million, or $0.39 per share net of income tax.

The Company's non-GAAP net income was $196 million, or $5.09 per diluted share, for the reported quarter compared with $170 million, or $4.42 per diluted share, for the prior year quarter. The results topped Wall Street's estimates of $4.90 per share.

Surgical Highlights

For Q1 FY17, Intuitive Surgical's worldwide da Vinci procedures grew nearly 18% on a y-o-y basis, driven primarily by growth in US general surgery procedures and worldwide urologic procedures. The Company shipped 133 da Vinci Surgical Systems in the reported quarter compared with 110 in the year earlier same quarter.

Cash Flow

Intuitive Surgical ended Q1 FY17 with $3.1 billion in cash, cash equivalents, and investments, a decrease of $1.7 billion during the reported quarter, primarily driven by the $2 billion used for accelerated share repurchases, yet partially offset by proceeds from cash generated from operations and employee stock option exercises.

Stock Performance

At the close of trading session on Thursday, April 20, 2017, Intuitive Surgical's share price finished yesterday's trading session at $814.45, rising slightly by 0.84%. A total volume of 394.36 thousand shares exchanged hands, which was higher than the 3 months average volume of 356.40 thousand shares. The stock has surged 23.77% and 26.36% in the last three months and past twelve months, respectively. Furthermore, since the start of the year, shares of the Company have surged 28.43%. The stock is trading at a PE ratio of 43.52 and currently has a market cap of $29.91 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 460226

Source URL: http://marketersmedia.com/post-earnings-coverage-as-intuitive-surgicals-quarterly-revenue-increased-13-eps-gained-15/189147

Source: AccessWire

Release ID: 189147


Latest News